From the Corner Office: Solenic Medical Reaches a Two-Year Anniversary Milestone

The two-year anniversary point in any startup provides an opportunity to reflect on the surprises and unexpected turns in the road, many of which could not have been predicted. Solenic Medical’s second year was unlike...

Zebra Analytix Receives NIH Grant for Rapid Breath Detection of Hazardous Substance Exposure

FAYETTEVILLE, AR - Zebra Analytix, Inc.—a VIC Technology Venture Development portfolio company—announced today that it has been awarded a National Institutes of Health (NIH) Small Business Innovation Research (SBIR)...

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

VIC Foundry, in collaboration with Sandia National Laboratories, is developing a self-contained isothermal nucleic acid amplification test to address an unmet need for at-home testing of COVID-19 infection. This...

VIC 2020 Annual Report Executive Summary

Despite the challenges 2020 brought, we saw promising progress for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.

VIC Fellows Spotlight: Kirt Gill, MD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Diabeloop SA and SFC Fluidics Announce Development Agreement

SFC Fluidics Inc., developer of an Alternate Controller Enabled (ACE) insulin delivery pod and Diabeloop, pioneer in therapeutic artificial intelligence, are partnering to integrate the SFC ACE insulin pod into...

CardioWise Receives US FDA 510(k) Clearance for Heart Function Analysis Software

CardioWise, Inc., is pleased to announce Clearance of its 510(k) application by the US Food and Drug Administration (FDA) for its heart function analysis software, Stretch Quantifier for Endocardial Engraved Zones...

A Letter from our CEO

When I wrote my last “letter from the CEO” in January 2020, I did not foresee the tumultuous year ahead. For so many, it’s been a tragic and difficult year on a personal level. We have all been impacted by the pandemic...

Neurexis Therapeutics Works to Solve an Unmet Healthcare Need

CBSA President & CEO, Jennifer Jones Paton, asked Michael Artinger, PhD, Neurexis’ Chief Executive Officer, CBSA’s Key Questions for Life Sciences Innovators.

VIC Investor Network Introduces a Secondary Market for Members

Provides VIN Members Early Liquidity Options FAYETTEVILLE, AR. DECEMBER 14, 2020- The VIC Investor Network (“VIN”) makes investments into companies based on technologies that can have substantial impact on human health...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Women Shaping Life Sciences: Laura Lyons on Purpose, Perseverance, and Patient-Centered Innovation
White Paper
Fostering Life Science Innovation: Part 2 – Inventing with the End in Mind
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Fostering Life Science Innovation: Part 1 – An Ecosystem Roadmap
News
SFC Fluidics Collaborating with Duracell to Power Innovative Diabetes Devices
Interview
VIC Fellows Spotlight: Nicole Shirkey-Son, PhD
From The Corner Office
From the Corner Office with Enhance Diagnostics